{
  "meta": {
    "title": "91_Community_Medicine_Aiims_2017",
    "url": "https://brainandscalpel.vercel.app/91-community-medicine-aiims-2017-6dca7613.html",
    "scrapedAt": "2025-11-30T12:58:36.283Z"
  },
  "questions": [
    {
      "text": "Which of the following wastes are disposed in the bag shown below?",
      "choices": [
        {
          "id": 1,
          "text": "Urine bags"
        },
        {
          "id": 2,
          "text": "Anatomical waste"
        },
        {
          "id": 3,
          "text": "Soiled waste"
        },
        {
          "id": 4,
          "text": "Sharp waste"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The above picture shows a <strong>red coloured bag</strong> which is used to <strong>dispose&nbsp;contaminated wastes (recyclable)</strong> such as tubing, bottles, intravenous tubes and sets, catheters, <strong>urine bags</strong>, syringes (without needles) and gloves.</p>\n<p><strong>Option B:</strong> <strong>Anatomical wastes</strong> go into <strong>yellow non-chlorinated plastic bags</strong>.<br /><strong>Option C</strong>: <strong>Soiled wastes</strong> go into <strong>yellow coloured non-chlorinated plastic bags.</strong><br /><strong>Option D:</strong> <strong>Sharp wastes</strong> go into <strong>white puncture proof, leak proof, tamper proof containers.</strong></p><hr><h3>Related Pearl: Biomedical waste disposal</h3><p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td colspan=\"2\">\n<p><span><strong>&nbsp;<span> Yellow bag </span></strong><strong><span>(non-chlorinated)</span></strong><strong><span>&nbsp;</span>&nbsp;</strong></span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Type of Waste</p>\n</td>\n<td>&nbsp;Treatment and Disposal Options</td>\n</tr>\n<tr>\n<td>\n<p><strong>Human anatomical waste</strong></p>\n<p><strong>Animal anatomical waste</strong></p>\n</td>\n<td>\n<p><strong>Incineration</strong>/Plasma pyrolysis/Deep Burial</p>\n</td>\n</tr>\n<tr>\n<td><strong>Soiled Waste: </strong>Items like dressings, cotton swabs, and plaster casts contaminated with blood and body fluids and bags containing residual discarded blood.</td>\n<td>\n<p><strong>Incineration</strong>/Plasma pyrolysis/Deep Burial</p>\n<p>or</p>\n<p>Autoclaving/Microwaving/ Hydroclaving</p>\n<p>Later - Shredding/mutilation</p>\n</td>\n</tr>\n<tr>\n<td>Discarded linen, mattresses, beddings contaminated with blood or body fluid,<strong> routine masks, and gowns</strong></td>\n<td>\n<p>Non- chlorinated chemical disinfection<br />followed by incineration or Plazma<br />Pyrolysis or for energy recovery.<br />In absence of the above facilities, shredding,&nbsp;mutilation, or a combination of&nbsp;sterilization and shredding is used.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Microbiology, biotechnology, clinical laboratory waste</strong></p>\n<p>(Autoclave safe plastic bags used)</p>\n<p><strong>Blood bags</strong>, laboratory<br />cultures, stocks or&nbsp;specimens of microorganisms,<br />live or&nbsp;attenuated vaccines,&nbsp;human and animal cell&nbsp;cultures used in&nbsp;research, industrial&nbsp;laboratories, production&nbsp;of biological, residual&nbsp;toxins, dishes, and&nbsp;devices used for&nbsp;cultures.</p>\n</td>\n<td>\n<p>Pre-treatment with nonchlorinated chemicals</p>\n<p>Later - Incineration</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Expired/discarded medicine, cytotoxic drugs</p>\n</td>\n<td>Incineration/plasma pyrolysis/ disposal in a secured landfill</td>\n</tr>\n<tr>\n<td>&nbsp;\n<p><strong>Chemical waste</strong></p>\n<p>Chemicals used in biological production&nbsp;and used or discarded<br />disinfectants.</p>\n</td>\n<td>\n<p>Disposal- incineration/plasma<br />pyrolysis</p>\n<p>Encapsulation-&nbsp;hazardous waste treatment, storage, and&nbsp;disposal facility.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Chemical liquid</strong>&nbsp;<strong>waste</strong> :<br />Liquid waste generated&nbsp;due to the use of chemicals&nbsp;in the production of<br />biological and used or&nbsp;<strong>discarded disinfectants,</strong>&nbsp;silver X-ray film<br />developing liquid,<br />discarded formalin,<br />infected <strong>secretions,</strong><br /><strong>aspirated body&nbsp;fluids</strong>,&nbsp;liquid from&nbsp;laboratories and floor&nbsp;washings, cleaning,&nbsp;house-keeping and<br />disinfecting activities&nbsp;etc.</p>\n<p>&nbsp;</p>\n</td>\n<td>After resource recovery, the chemical<br />liquid waste shall be pre-treated before&nbsp;mixing with other wastewater.&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td colspan=\"2\">\n<p><span><strong>&nbsp; Red&nbsp;bag (non-chlorinated)&nbsp;&nbsp;</strong></span></p>\n</td>\n</tr>\n<tr>\n<td><strong>&nbsp;Type of Waste</strong></td>\n<td>\n<p><strong>&nbsp;<span>Treatment and Disposal Options</span></strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Recyclable contaminated</strong> waste</p>\n<p>Contaminated waste tubing, bottles, intravenous tubes and sets, <strong>catheters,</strong> <strong>urine bags</strong>, syringes (without needles and fixed needle syringes with their needles cut), <strong>vacutainers with</strong> <strong>needles cut,</strong> and gloves.</p>\n</td>\n<td>\n<p><strong>Autoclaving/Microwaving/<br />Hydroclaving</strong></p>\n<p>Followed by Shredding/mutilation</p>\n<p>And later, Energy recovery/Plastics to diesel or fuel oil/road-making</p>\n<p>Not to be sent to landfill</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td colspan=\"2\">\n<p><strong>&nbsp; White (translucent)&nbsp;&nbsp;<br />(puncture-proof, leak-proof containers)</strong></p>\n</td>\n</tr>\n<tr>\n<td><strong>Type of Waste</strong></td>\n<td>\n<p><strong>Treatment and Disposal Options</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Waste Sharps including metals.</strong></p>\n<p>Needles, syringes with fixed needles, needles from needle tip cutter or burner, scalpels, blades, or any other <strong>contaminated sharp</strong> object that may cause puncture and cuts. This includes both used, discarded, and contaminated metal sharps</p>\n</td>\n<td>\n<p>Autoclaving/ Dry heat sterilization</p>\n<p>Followed by - <strong>Shredding/mutilation</strong>/<br />encapsulation</p>\n<p>Later by - Iron foundries/sanitary landfill/waste sharps</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td colspan=\"2\">\n<p>&nbsp;<span><strong><span>&nbsp; Blue&nbsp;&nbsp;</span><br /></strong></span><span><strong><span>(Puncture proof and leak proof containers with blue colored marking)</span></strong></span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Type of Waste&nbsp;</strong></p>\n</td>\n<td>\n<p><strong>&nbsp;Treatment and Disposal Options</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Glassware</strong></p>\n<p>Broken or discarded and contaminated glass including medicine <strong>vials</strong> and <strong>ampules except</strong> those containing <strong>cytotoxic</strong> waste.</p>\n<p><strong>Metallic body implants</strong></p>\n</td>\n<td>\n<p>Sodium hypochlorite/Autoclaving/<br />Microwaving/Hydroclaving</p>\n<p>Later - Recycling</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<p>&nbsp;Note: <strong>Ash</strong> from the <strong>incineration</strong> of biomedical waste shall be disposed of at a <strong>common hazardous waste treatment and disposal facility</strong>. However, it may also be disposed of in a <strong>municipal landfill</strong>, <strong>if</strong> the toxic metals in incineration ash are <strong>within</strong> the <strong>regulatory quantities</strong> as defined under the Hazardous Waste (Management and Handling and Transboundary Movement) Rules, 2008 as amended from time to time.</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/204d3e521e0a4ff6b35b363d9eb057db.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA1141",
      "difficulty": "easy"
    },
    {
      "text": "A researcher discovered a new drug which is effective in chronic hypertensives  with a p value of <0.10. which of the following is true regarding the same",
      "choices": [
        {
          "id": 1,
          "text": "Not more than 10% of the people benefitted by the drug could be due to chance"
        },
        {
          "id": 2,
          "text": "90% of patients will be benefitted by giving the drug"
        },
        {
          "id": 3,
          "text": "The test is 90% reproducible"
        },
        {
          "id": 4,
          "text": "90% of test results could  have occurred by chance"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>P value &lt;0.10 indicates that not more than 10% of people benefitted by the drug could be due to chance.</p>\n<p>It can also be interpreted as</p>\n<ul>\n<li>If the test is repeated 100 times, the difference will be statistically non significant only 10 times and difference will be statistically significant 90 times.</li>\n<li>Probability of false positive conclusion that drug is beneficial which in reality is not, is 10%.</li>\n</ul>\n<p>It arises in case of statistical studies to accept or reject a null hypothesis.</p>\n<p>P value is compared with a predetermined value &alpha;; P value &lt; &alpha; means the test is statistically significant and null hypothesis is rejected.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA1139",
      "difficulty": "medium"
    },
    {
      "text": "Below is the graph of CD4 count in HIV patients. From the graph below identify the mean CD 4 count",
      "choices": [
        {
          "id": 1,
          "text": "300-400"
        },
        {
          "id": 2,
          "text": "200-300"
        },
        {
          "id": 3,
          "text": "Below 250"
        },
        {
          "id": 4,
          "text": "Above 350"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given data should be converted into numerical table. Small approximations can be made while converting into numerical form.</p>\n<table>\n<tbody>\n<tr>\n<td>CD4 Count</td>\n<td>Number of people</td>\n</tr>\n<tr>\n<td>&lt;100</td>\n<td>5</td>\n</tr>\n<tr>\n<td>100 - 200</td>\n<td>10</td>\n</tr>\n<tr>\n<td>200 - 300</td>\n<td>25</td>\n</tr>\n<tr>\n<td>300 - 400</td>\n<td>35</td>\n</tr>\n<tr>\n<td>400 - 500</td>\n<td>20</td>\n</tr>\n<tr>\n<td>&gt;500</td>\n<td>5</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>Since intervals are given, midpoint of each interval has to be calculated.</p>\n<p>It should then be multiplied with frequency of that particular interval.</p>\n<p>Mean is given by the formula: <strong>Mean &nbsp;= Sum of all observations / number of observations.</strong></p>\n<table>\n<tbody>\n<tr>\n<td>CD4 Count</td>\n<td>Mid point</td>\n<td>Number of people (n)</td>\n<td>Mid point&nbsp;&times; n</td>\n</tr>\n<tr>\n<td>0 - 100</td>\n<td>50</td>\n<td>5</td>\n<td>250</td>\n</tr>\n<tr>\n<td>100 - 200</td>\n<td>150</td>\n<td>10</td>\n<td>1500</td>\n</tr>\n<tr>\n<td>200 - 300</td>\n<td>250</td>\n<td>25</td>\n<td>6250</td>\n</tr>\n<tr>\n<td>300 - 400</td>\n<td>350</td>\n<td>35</td>\n<td>12250</td>\n</tr>\n<tr>\n<td>400 - 500</td>\n<td>450</td>\n<td>20</td>\n<td>9000</td>\n</tr>\n<tr>\n<td>500 - 1600</td>\n<td>1050</td>\n<td>5</td>\n<td>5250</td>\n</tr>\n<tr>\n<td>TOTAL</td>\n<td>&nbsp;</td>\n<td>100</td>\n<td>34500</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>Mean = 34500/100 = 345. <br />Between 300 -400 is the most suitable answer.</p><p><strong>The normal range of CD4 cells is 500-1600.</strong></p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/0d97e6b61c9147a6afafb27696a9c13f.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA1140",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is true about triage?",
      "choices": [
        {
          "id": 1,
          "text": "Yellow – least priority"
        },
        {
          "id": 2,
          "text": "Red – mortality"
        },
        {
          "id": 3,
          "text": "Green – ambulatory"
        },
        {
          "id": 4,
          "text": "Blue – ambulatory"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>In triage, <strong>green</strong> signifies <strong>low</strong> priority or ambulatory patients and those with minor illnesses.</p>\n<p>An internationally accepted <strong>four-color coded</strong> system, with red having the highest priority is used commonly here.</p><hr><h3>Related Pearl: Triage Colour Coding</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/515d17fd0b684f8b9cd1fd57ef97b7e6x454x304.PNG\" alt=\"Pearl Image\"><p>&nbsp;<strong>Triage system </strong>consists of <strong>four colour codes:</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Color code</strong></td>\n<td><strong>Type of patients</strong></td>\n<td><strong>Examples</strong></td>\n</tr>\n<tr>\n<td><span>Red (High priority)<br /></span></td>\n<td>\n<p>Need for<strong> immediate resuscitation or surgery</strong> in the next<strong> 6 hours</strong> or transfer.</p>\n<p>May survive if timely medical intervention can be given</p>\n</td>\n<td>\n<ul>\n<li>Tension pneumothorax</li>\n<li>Airway obstruction</li>\n<li>Hemothorax</li>\n<li>Cardiac tamponade</li>\n<li>Acute circulatory arrest</li>\n<li>Major intra-abdominal bleed etc.</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><span>Yellow (Medium priority)<br /></span></td>\n<td>\n<p>Possible <strong>resuscitation or surgery</strong> in the <strong>next 24 hours</strong>.</p>\n<p>Likely to survive if prompt treatment is given.</p>\n</td>\n<td>\n<ul>\n<li>Compound fractures</li>\n<li>Degloving injuries</li>\n<li>Pelvic fracture</li>\n<li>Spinal injuries</li>\n<li>Moderate head injury</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><span>Green (Low priority)<br /></span></td>\n<td>\n<p><strong>Ambulatory patients</strong> or minor illnesses.</p>\n<p>Likely to survive if treatment is slightly delayed.</p>\n</td>\n<td>\n<ul>\n<li>Simple fractures</li>\n<li>Minor lacerations etc.</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Black (Least priority)</td>\n<td>\n<p><strong>Dead or moribund</strong> patients.</p>\n</td>\n<td>\n<ul>\n<li>Severe brain injury</li>\n<li>Major damage / disruption to chest wall and abdominal structures</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2626",
      "difficulty": "easy"
    },
    {
      "text": "A randomized trial comparing the efficacy of two drugs showed a difference between the two with a p value of <0.005. In reality, both drugs do not differ at all. This is an example of:",
      "choices": [
        {
          "id": 1,
          "text": "Alpha error"
        },
        {
          "id": 2,
          "text": "Beta error"
        },
        {
          "id": 3,
          "text": "1 – α"
        },
        {
          "id": 4,
          "text": "1 – β"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<ul>\n<li>In this scenario, let&rsquo;s take the null hypothesis as the two drugs being the same, which the questions states, is true in reality.</li>\n<li>The alternative hypothesis will then be that both drugs are different.</li>\n<li>The questions states that <strong>p value was found to be &lt; 0.005</strong>, which is <strong>statistically significant</strong> and so the <strong>null hypothesis is rejected</strong>.</li>\n<li>But we already know that the null hypothesis is true and we are forced to accept the alternative hypothesis even though it is false.</li>\n<li>This is a <strong>type I error or alpha error</strong>.</li>\n<li>When an alternative hypothesis is accepted even when it is false and the null hypothesis is true, it is a type I error or false positive error.</li>\n</ul><hr><h3>Related Pearl: Concepts in Hypothesis Testing</h3><p><strong>Probability value (</strong><em>p</em><strong> value)</strong></p>\n<ul>\n<li>A&nbsp;<strong>probability value</strong>&nbsp;is the&nbsp;<strong>probability of an outcome given the hypothesis</strong>.</li>\n<li>It is not the probability of the hypothesis given the outcome, although the probability of the given hypothesis is not ignored.</li>\n<li>If the&nbsp;<strong>probability of an outcome is sufficiently low</strong>, we have&nbsp;<strong>evidence that the hypothesis is false</strong>.</li>\n<li>It is also called the&nbsp;<em>p</em><strong> value</strong>.</li>\n</ul>\n<p><strong>The Null Hypothesis and Alternative Hypothesis</strong></p>\n<ul>\n<li>The <strong>hypothesis that an apparent effect or outcome is only due to chance is a null hypothesis</strong>.</li>\n<li>In other words, a null hypothesis is one where there is <strong>no difference between the specified sample and population</strong> and any observed difference is due to chance or some other error.</li>\n<li>A null hypothesis is represented by <strong>H<sub>0</sub></strong>.</li>\n<li>If the <strong>null hypothesis</strong> is <strong>rejected</strong> as false, then there is an <strong>alternative</strong> or <strong>experimental hypothesis (H<sub>A</sub>)</strong>, which is logically accepted.</li>\n</ul>\n<p><strong>Criterion or Significance Level</strong> <strong>(&alpha;) </strong></p>\n<ul>\n<li>If the probability value of an outcome is sufficiently low, then the null hypothesis is rejected.</li>\n<li>This <strong>point below which we would define the probability value as being low enough</strong> to reject the null hypothesis is called the <strong>criterion</strong> or <strong>significance level </strong>or<strong> &alpha; (alpha) level</strong>.</li>\n<li>When the null hypothesis is rejected, the effect or outcome is said to be <strong>statistically significant</strong>.</li>\n<li>By <strong>convention</strong> (but not always), the <strong>level of &alpha; is 0.05</strong>, i.e., if the probability value of an outcome is <strong>less than or equal to 0.05 (</strong><em>p</em><strong> value &le; 0.05)</strong>, then the null hypothesis is <strong>rejected</strong>.</li>\n<li>If it is <strong>greater than 0.05</strong>, then the null hypothesis is <strong>accepted</strong>.</li>\n<li>Although by convention the level of <strong>&alpha; is 0.05</strong>, it can be lower but cannot be any higher.</li>\n</ul>\n<p><strong>Type I Error</strong></p>\n<ul>\n<li>The interpretation of <strong><em>p</em> value &le; 0.05 </strong>is that an investigator can be 95% sure that the result was not obtained by chance.</li>\n<li>It also means that there is a 5% probability that the result was obtained by chance.</li>\n<li>From this, we can deduce that the <strong>null hypothesis might indeed be true even though we rejected it</strong>.</li>\n<li>This is <strong>a type I error</strong>. In other words, <strong>when an alternative hypothesis is accepted even when it is false and the null hypothesis is true</strong>, it is a <strong>type I error</strong> or <strong>false positive error</strong>.</li>\n<li>It is also called an <strong>alpha (&alpha;) error</strong> as it is <strong>related to the criterion &alpha;</strong>.</li>\n<li>The <strong>lower the &alpha; level</strong>, the <strong>lower the rate of a type I error</strong> being made.</li>\n<li>Thus, it can be said that <strong>&alpha; is the maximum tolerable probability that a type I error is being made</strong> and that the <strong>p value is the probability that a significant difference is declared when there is none</strong>.</li>\n</ul>\n<p><strong>Type II Error</strong></p>\n<ul>\n<li>The error that is made by <strong>rejecting an alternative hypothesis when it is true</strong> or <strong>failing to reject a null hypothesis when it is false</strong> is called a <strong>type II error</strong>.</li>\n<li>It is also called a <strong>false negative error </strong>and more commonly, as a <strong>beta (&beta;) error</strong>.</li>\n<li>If the null hypothesis is false, then the <strong>probability of a type II error</strong> is <strong>&beta;</strong>.</li>\n<li>The <strong>power of a statistical test</strong> is indicated by <strong>1&ndash;&beta;.</strong></li>\n</ul>\n<p><strong>Power of a Test</strong></p>\n<ul>\n<li>The <strong>power of a test</strong> is the <strong>ability</strong> of a statistical test to <strong>avoid a type II error</strong>, which depends on its <strong>ability to detect a false null hypothesis</strong>.</li>\n<li>It is <strong>equal to 1&ndash;&beta;</strong>, which is the <strong>probability that a false null hypothesis will be rejected</strong>.</li>\n<li>By <strong>convention</strong>, a test is required to have a <strong>power of 0.8</strong> (or a <strong>&beta; of 0.2</strong>) to be <strong>acceptable</strong>. This is to say that a study that has less than 80% chance of detecting a false null hypothesis is unacceptable.</li>\n<li><strong>Type I errors are easily reduced by reducing the criterion &alpha;</strong>.</li>\n<li>A <strong>test's power will increase</strong> in the following conditions:\n<ul>\n<li>If <strong>&alpha; increases</strong>, but this will increase the chance of a type I error.</li>\n<li>If the <strong>difference between </strong>the <strong>sample mean </strong>and<strong> hypothesized mean increases</strong>. This is also called <strong>effect size</strong>.</li>\n<li>If <strong>sampling error decreases</strong>.</li>\n<li>If the <strong>sample size (n) increases</strong>.</li>\n</ul>\n</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB3979",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following vaccine vials can be used based on the vaccine vial monitor (VVM) color changes shown?",
      "choices": [
        {
          "id": 1,
          "text": "Only vial 1 can be used"
        },
        {
          "id": 2,
          "text": "Vials 1 and 2 can be used"
        },
        {
          "id": 3,
          "text": "Vials 1, 2, and 3 can be used"
        },
        {
          "id": 4,
          "text": "All vials can be used"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>From the above image, only <strong>vials 1 </strong>and<strong> 2</strong> can be <strong>used</strong> as the <strong>inner squares</strong> of the VVMs are<strong> lighter than</strong> the <strong>outer circles</strong>.</p>\n<p>Vial 3 has crossed the discard point as the inner square and outer circle are the same color and thus cannot be used. Vial 4 cannot be used as the VVM shows a darker inner square compared to the outer circle.</p><hr><h3>Related Pearl: Vaccine Vial Monitors</h3><ul>\n<li><strong>Vaccine vial monitors</strong> are used to monitor heat exposure of vaccines.</li>\n<li>It is a chemical indicator that records the cumulative heat exposure through a gradual change in color.</li>\n<li>If the color of the <strong>inner square</strong> is the <strong>same color or darker</strong> than the <strong>outer circle</strong>, it indicates that the vaccine has been exposed to too much heat and it must be <strong>discarded</strong>.</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/3914a3eb19cf43ec9273112090e7b3f6x600x1199.JPEG\" alt=\"Pearl Image\"><ul>\n<li>Currently, there are <strong>four types</strong> of VVMs (VVM2, VVM7, VVM14, and VVM30). They are chosen to match the heat sensitivity of the vaccine.</li>\n<li>The VVM can be located on the label of the vaccine or on the neck or cap of the ampule/vial.</li>\n<li>VVMs also help in <strong>reduction of vaccine wastage</strong> by indicating which batch of vaccines can be used first.</li>\n</ul>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/72cf73b7676c4d6e9f9a49b34d21377e.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB9218",
      "difficulty": "easy"
    },
    {
      "text": "Under the Mid-Day Meal (MDM) scheme, supplementary nutrition provided should cover at least _______",
      "choices": [
        {
          "id": 1,
          "text": "1/3 of the total protein requirement + ½ of total energy requirement"
        },
        {
          "id": 2,
          "text": "2/3 of the total protein requirement + ½ of total energy requirement"
        },
        {
          "id": 3,
          "text": "½ of the total protein requirement + 1/3 of total energy requirement"
        },
        {
          "id": 4,
          "text": "½ of the total protein requirement + 2/3 of total energy requirement"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Under the<strong> Mid-Day Meal</strong> (MDM) <strong>scheme</strong>, supplementary nutrition provided must cover at least <strong>&frac12; of the total protein requirement and 1/3 of total energy requirement</strong> to children in schools.</p>\n<p>The MDM scheme is also called <strong>School Lunch Programme</strong> and has been operational since 1961 in India. Currently, it functions under the broad coverage of the<strong> Minimum Needs Programme</strong>.</p>\n<p>Some other principles of the MDM are:</p>\n<ul>\n<li>The meal provided under the MDM should only be a <strong>supplement</strong> and not a substitute to home diets.</li>\n<li>The<strong> cost of the meals should be reasonably low.</strong></li>\n<li>The meal should be <strong>easy to cook</strong> in schools.</li>\n<li><strong>Locally available foods</strong> must be used, for as far as possible.</li>\n<li>The menu should be <strong>regularly changed</strong> to avoid monotony.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB9178",
      "difficulty": "medium"
    },
    {
      "text": "In a subcentre area with a crude birth rate (CBR) of 20, what would be the expected number of antenatal care (ANC) registrations by the village health nurse (VHN) in a year?",
      "choices": [
        {
          "id": 1,
          "text": "60"
        },
        {
          "id": 2,
          "text": "80"
        },
        {
          "id": 3,
          "text": "100"
        },
        {
          "id": 4,
          "text": "110"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<ul>\n<li>According to the <strong>Indian Public Health Standards (IPHS)</strong> laid down by the Government of India, a <strong>subcentre is to serve a population of 5000</strong> in plains.</li>\n<li>In this scenario, the CBR is 20.</li>\n<li><strong>Probable number of pregnancies (Y) = Birth rate x population of the area / 1000 = 20 x 5000/1000 = 100.</strong></li>\n<li>But, we add a correction factor of 10% to adjust for pregnancy wastage in the form of abortions or stillbirths.&nbsp;</li>\n<li>Thus, <strong>total number of expected pregnancies= Y + 10% of Y= 110</strong></li>\n<li>As all the pregnancies are not registered, and at any given time an ANM should have atleast half the expected pregnancies registered with her, the number of ANC registrations is taken as 50% of the expected pregnancies.</li>\n<li><strong>Therefore, Total ANC registrations</strong> = <strong>total number of expected pregnancies/2 = 55</strong></li>\n<li><strong>Hence, the closest answer is 60.</strong></li>\n</ul>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB9123",
      "difficulty": "hard"
    },
    {
      "text": "As per the syndromic approach to sexually transmitted infections (STIs) and reproductive tract infections (RTIs), what is the treatment of choice of gonococcal and non-gonococcal urethritis?",
      "choices": [
        {
          "id": 1,
          "text": "Azithromycin + Metronidazole"
        },
        {
          "id": 2,
          "text": "Cefixime + Azithromycin"
        },
        {
          "id": 3,
          "text": "Azithromycin + Doxycycline"
        },
        {
          "id": 4,
          "text": "Doxycycline + Cefixime"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>As per the syndromic approach to STIs/RTIs, the treatment of choice of for gonococcal and non-gonoccocal urethritis is <strong>azithromycin + cefixime.</strong></p><hr><h3>Related Pearl: Syndromic Management of Sexually Transmitted Infections</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/1167210a9cd6434a905a98bc64668d41x1280x2612.PNG\" alt=\"Pearl Image\"><p>Partner Management when <strong>asymptomatic</strong> is not required for <strong>Gardenella vaginalis, Candida and Herpes infections</strong>.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/60da7b1257d04ca5938ef3340533e6b9x1280x2974.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB9129",
      "difficulty": "medium"
    },
    {
      "text": "Annual new case detection rate (ANCDR) of leprosy in India, as of 31st March 2016 was ________.",
      "choices": [
        {
          "id": 1,
          "text": "0.66/10,000 population"
        },
        {
          "id": 2,
          "text": "0.66/1 lakh population"
        },
        {
          "id": 3,
          "text": "9.7/10,000 population"
        },
        {
          "id": 4,
          "text": "9.7/1 lakh population"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>For the year 2015 – 2016, the <strong>annual new case detection rate </strong>(ANCDR) of leprosy in India was <strong>9.7/100,000 population.</strong></p><p>Update: During<strong> </strong>the year<strong> 2021-2022</strong>, India reported 75,394 new cases with an ANCDR of<strong> 5.09/1,00,000 population.</strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB9156",
      "difficulty": "hard"
    },
    {
      "text": "The recommended calorie intake for a pregnant woman in the second trimester, who is a sedentary worker would increase by _______",
      "choices": [
        {
          "id": 1,
          "text": "600 kcal/day"
        },
        {
          "id": 2,
          "text": "520 kcal/day"
        },
        {
          "id": 3,
          "text": "450 kcal/day"
        },
        {
          "id": 4,
          "text": "350 kcal/day"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The recommended calorie intake for a <strong>pregnant woman</strong> who is a sedentary worker would increase by ~&nbsp;<strong>350 kcal/day</strong>.</p>\n<p>&nbsp;</p><hr><h3>Related Pearl: Recommended Dietary Allowances For Energy And Protein For Indians</h3><table>\n<tbody>\n<tr>\n<td> </td>\n<td><strong>Category</strong></td>\n<td><strong>EAR - Energy(Kcal/D) </strong></td>\n<td><strong> RDA - Protein (g/D) </strong></td>\n</tr>\n<tr>\n<td>Man</td>\n<td>\n<ul>\n<li data-leveltext=\"\" data-font=\"Symbol\" data-listid=\"3\" aria-setsize=\"-1\" data-aria-posinset=\"1\" data-aria-level=\"1\">Sedentary work </li>\n<li data-leveltext=\"\" data-font=\"Symbol\" data-listid=\"3\" aria-setsize=\"-1\" data-aria-posinset=\"2\" data-aria-level=\"1\">Moderate work </li>\n<li data-leveltext=\"\" data-font=\"Symbol\" data-listid=\"3\" aria-setsize=\"-1\" data-aria-posinset=\"3\" data-aria-level=\"1\">Heavy work  </li>\n</ul>\n</td>\n<td>\n<ul>\n<li data-leveltext=\"\" data-font=\"Symbol\" data-listid=\"3\" aria-setsize=\"-1\" data-aria-posinset=\"1\" data-aria-level=\"1\">2110 </li>\n<li data-leveltext=\"\" data-font=\"Symbol\" data-listid=\"3\" aria-setsize=\"-1\" data-aria-posinset=\"2\" data-aria-level=\"1\">2710 </li>\n<li data-leveltext=\"\" data-font=\"Symbol\" data-listid=\"3\" aria-setsize=\"-1\" data-aria-posinset=\"3\" data-aria-level=\"1\">3470 </li>\n</ul>\n</td>\n<td>\n<ul>\n<li data-leveltext=\"\" data-font=\"Symbol\" data-listid=\"3\" aria-setsize=\"-1\" data-aria-posinset=\"1\" data-aria-level=\"1\">54</li>\n<li data-leveltext=\"\" data-font=\"Symbol\" data-listid=\"3\" aria-setsize=\"-1\" data-aria-posinset=\"2\" data-aria-level=\"1\">54</li>\n<li data-leveltext=\"\" data-font=\"Symbol\" data-listid=\"3\" aria-setsize=\"-1\" data-aria-posinset=\"3\" data-aria-level=\"1\">54</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Woman </td>\n<td>\n<ul>\n<li>Sedentary work </li>\n<li data-leveltext=\"\" data-font=\"Symbol\" data-listid=\"3\" aria-setsize=\"-1\" data-aria-posinset=\"2\" data-aria-level=\"1\">Moderate work </li>\n<li data-leveltext=\"\" data-font=\"Symbol\" data-listid=\"3\" aria-setsize=\"-1\" data-aria-posinset=\"3\" data-aria-level=\"1\">Heavy work </li>\n<li data-leveltext=\"\" data-font=\"Symbol\" data-listid=\"3\" aria-setsize=\"-1\" data-aria-posinset=\"4\" data-aria-level=\"1\">Pregnancy <br /><br /><br /></li>\n<li data-leveltext=\"\" data-font=\"Symbol\" data-listid=\"3\" aria-setsize=\"-1\" data-aria-posinset=\"5\" data-aria-level=\"1\">Lactation (0-6m) </li>\n<li data-leveltext=\"\" data-font=\"Symbol\" data-listid=\"3\" aria-setsize=\"-1\" data-aria-posinset=\"6\" data-aria-level=\"1\">Lactation (6-12m) </li>\n</ul>\n</td>\n<td>\n<ul>\n<li>1660</li>\n<li>2130</li>\n<li>2720 </li>\n<li>+340 (2nd trimester)<br />+452 (3rd trimester)</li>\n<li data-leveltext=\"\" data-font=\"Symbol\" data-listid=\"3\" aria-setsize=\"-1\" data-aria-posinset=\"5\" data-aria-level=\"1\">+600 </li>\n<li data-leveltext=\"\" data-font=\"Symbol\" data-listid=\"3\" aria-setsize=\"-1\" data-aria-posinset=\"6\" data-aria-level=\"1\">+520 </li>\n</ul>\n</td>\n<td>\n<ul>\n<li>46</li>\n<li data-leveltext=\"\" data-font=\"Symbol\" data-listid=\"3\" aria-setsize=\"-1\" data-aria-posinset=\"2\" data-aria-level=\"1\">46</li>\n<li data-leveltext=\"\" data-font=\"Symbol\" data-listid=\"3\" aria-setsize=\"-1\" data-aria-posinset=\"3\" data-aria-level=\"1\">46</li>\n<li data-leveltext=\"\" data-font=\"Symbol\" data-listid=\"3\" aria-setsize=\"-1\" data-aria-posinset=\"3\" data-aria-level=\"1\">+9.5(2nd trimester)<br />+22 (3rd trimester)<br /><br /></li>\n<li data-leveltext=\"\" data-font=\"Symbol\" data-listid=\"3\" aria-setsize=\"-1\" data-aria-posinset=\"5\" data-aria-level=\"1\">+17  </li>\n<li data-leveltext=\"\" data-font=\"Symbol\" data-listid=\"3\" aria-setsize=\"-1\" data-aria-posinset=\"6\" data-aria-level=\"1\">+13 </li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Infant</td>\n<td>\n<ul>\n<li>0-6 months</li>\n<li>6-12 months</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>530</li>\n<li>660</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>8.0</li>\n<li>10.5</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><strong>Dietary Reference Intakes</strong></p>\n<ul>\n<li>Recommended Dietary Allowance (RDA) - The average daily dietary intake that is sufficient to meet the requirements of almost all individuals in a group</li>\n<li>Estimated Average Requirement (EAR) - A nutrient intake value that is estimated to meet the requirements of half the individuals in a group</li>\n</ul>\n<p>The EAR for an <strong>elderly male </strong>(&gt;60 years) is <strong>1700 Kcal/D</strong> and for an <strong>elderly female </strong>(&gt;60 years) is <strong>1500 Kcal/D</strong>.</p>\n<p>Note: There is no RDA for energy. The EAR is equivalent to Estimated Energy Requirement (EER).</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB9203",
      "difficulty": "easy"
    },
    {
      "text": "Match the following declarations to their significance.",
      "choices": [
        {
          "id": 1,
          "text": "I – A, II – B, III – C, IV – D"
        },
        {
          "id": 2,
          "text": "I - C, II - D, III - A, IV - B"
        },
        {
          "id": 3,
          "text": "I – D, II – C, III – A, IV - B"
        },
        {
          "id": 4,
          "text": "I – B, II – A, III – D, IV - C"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<table>\n<tbody>\n<tr>\n<td><strong>Declaration</strong></td>\n<td>Significance</td>\n</tr>\n<tr>\n<td><strong>Geneva</strong></td>\n<td>Physician&rsquo;s dedication to the humanitarian goals of medicine.</td>\n</tr>\n<tr>\n<td><strong>Oslo</strong></td>\n<td>Statement on therapeutic abortion.</td>\n</tr>\n<tr>\n<td><strong>Tokyo</strong></td>\n<td>Guidelines for physicians concerning torture and other cruel, inhuman or degrading treatment or punishment in relation to detainment or imprisonment.</td>\n</tr>\n<tr>\n<td><strong>Helsinki</strong></td>\n<td>Set of ethical principles directed to the medical community for human experimentation.</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Health-related International Declarations:</h3><ol>\n<li><strong>Declaration of Alma-Ata (1978): </strong>Identified <strong>primary health care</strong> as the key to the attainment of the <strong>goal of Health for All.</strong></li>\n<li><strong>Ottawa&nbsp;Charter&nbsp;for&nbsp;Health&nbsp;Promotion (1986):&nbsp;</strong>The&nbsp;aim&nbsp;of&nbsp;the&nbsp;conference&nbsp;was&nbsp;to&nbsp;continue to&nbsp; achieve&nbsp;the&nbsp;<strong>objectives&nbsp;of&nbsp;the&nbsp;World&nbsp;Health Organization&nbsp;(WHO)&nbsp;Health&nbsp;for&nbsp;all by&nbsp;the&nbsp;year 2000</strong>.</li>\n</ol><p>3.&nbsp;<strong>Declaration of Oslo (1970): </strong>Related to<strong> therapeutic abortion.</strong></p>\n<p>4.&nbsp;<strong>Declaration of Tokyo (1975): </strong>Guidelines for medical doctors concerning <strong>torture </strong>and other cruel, inhuman or degrading treatment or punishment in relation to detention and imprisonment. (<strong>T </strong>&ndash; <strong>T</strong>okyo &ndash; <strong>T</strong>orture)</p>\n<p>5.&nbsp;<strong>Declaration of Helsinki (1975): </strong>Related to<strong> human experimentation. (H</strong> &ndash; <strong>H</strong>elsinki &ndash; <strong>H</strong>uman experimentation)</p>\n<p>6.&nbsp;<strong>Declaration of Geneva (1948): </strong>Most <strong>recent amendment</strong> was done on <strong>October 14, 2017 in Chicago. </strong> It gives the <strong>modern version of the 2500-year-old Hippocratic Oath</strong> which laid down the <strong>fundamental principles of medical ethics</strong> that any physician should follow.</p>\n<p>7.&nbsp;<strong>Declaration of Malta (1991, revised in 1992): Related to hunger strikes.</strong></p>\n<p>8.&nbsp;<strong>Declaration of Lisbon: </strong>Related to<strong> rights of the patients like right to information, confidentiality, dignity, freedom of choice etc.</strong></p>\n<p>9.&nbsp;<strong>Declaration of Sydney on human death: </strong> <strong>It </strong>stated that the <strong>determination of death</strong> &ldquo;will be <strong>based on clinical judgment, supplemented if necessary by a number of diagnostic aids</strong>&rdquo;, emphasising the <strong>EEG</strong>. Nonetheless, it asserted that &ldquo;the <strong>overall judgment of the physician&rdquo; could not be replaced by any ancillary test.</strong></p>\n<p>The statement also recommended that <strong>two or more physicians should make the diagnosis of death</strong> when organs were removed for <strong>transplantation.</strong></p>\n<p>10.&nbsp;<strong>Declaration of Istanbul: </strong>To address the urgent and growing problems of <strong>organ sales, transplant tourism and trafficking in organ donors</strong> in the context of the global shortage of organs.</p>\n<p>11.&nbsp;<strong>Declaration of Taipei</strong>: Related to ethical considerations regarding health databases and biobanks.</p>\n<p>&nbsp;</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/51b6dd1ba04a4ff78062898f4e6c42bc.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB9175",
      "difficulty": "medium"
    },
    {
      "text": "Chronic liver disease is classified using the Child-Pugh score as follows:  Class A: 5-6 ,  Class B: 7-9,  Class C: 10-15. What type of data is this scoring system?",
      "choices": [
        {
          "id": 1,
          "text": "Nominal"
        },
        {
          "id": 2,
          "text": "Ordinal"
        },
        {
          "id": 3,
          "text": "Qualitative"
        },
        {
          "id": 4,
          "text": "Metric"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The <strong>Child-Pugh score</strong> is an <strong>ordinal scale</strong> of data as:</p>\n<p>There is a <strong>rank order</strong> (Class A having a better prognosis than classes B and C) but no regular interval between each class. The final division of prognosis is based on class and not the numerical values arrived at by the summation of a set of variables.</p>\n<p>Other options:</p>\n<p>Option A: The Child-Pugh score cannot be a nominal scale of data as there is a rank order with class A having better survival statistics than B or C. Nominal data do not have a rank order.</p>\n<p>Option C: This is also not merely a qualitative scale as there are scores given to each variable to arrive at the final class.</p>\n<p>Option D: The data used in the Child-Pugh score cannot be merely metric as the final division of prognosis is based on class and not the numerical values. Also, there is no definite interval between the classes.</p><hr><h3>Related Pearl: Scales of data measurement</h3><p>Data can be <strong>quantitative</strong> (numerical values) or <strong>qualitative</strong> (types, labels).</p>\n<p>Quantitative data can be <strong>discrete variables </strong>or<strong> continuous variables.</strong></p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>&nbsp;</strong></p>\n</td>\n<td>\n<p>Description</p>\n</td>\n<td>\n<p>Example</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Discrete data</strong></p>\n</td>\n<td>\n<p>Can take&nbsp;<strong>certain values and none in between</strong></p>\n</td>\n<td>\n<p>Number of cancer patients in a hospital.&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Continuous data</strong></p>\n</td>\n<td>\n<p>Can <strong>take any value </strong>usually in between limits or a range.&nbsp;</p>\n</td>\n<td>\n<p>Most biomedical data is continuous.</p>\n<p>Height, weight, blood pressure, etc.</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<p>Data always forms one of four <strong>scales of measurement</strong> &ndash; <strong>nominal, ordinal, interval, or ratio</strong> scales (mnemonic: <strong>NOIR):</strong></p>\n<table>\n<tbody>\n<tr>\n<td>\n<p>&nbsp;</p>\n</td>\n<td>\n<p><strong>Nominal Scale Data</strong></p>\n</td>\n<td>\n<p><strong>Ordinal Scale Data</strong></p>\n</td>\n<td>\n<p><strong>Interval Scale Data</strong></p>\n</td>\n<td>\n<p><strong>Ratio Scale Data</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Example</p>\n</td>\n<td>\n<p>Male/female; red/green; sub-urban/rural</p>\n</td>\n<td>\n<p>Students ranked 1st/2nd/3rd in their class.&nbsp;</p>\n<p>A customer feedback survey using terms like very good, good, poor and very poor or the <strong>Likert Scale.</strong></p>\n<p>Severity of a disease as mild, moderate, severe</p>\n<p>&nbsp;</p>\n</td>\n<td>Measurements on the celsius scale.</td>\n<td>Pulse rate;&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Notes</p>\n</td>\n<td>\n<p>Have <strong>no quantitative value</strong>.</p>\n<p>They have no order or ratio.&nbsp;</p>\n</td>\n<td>\n<p>Arranged in a <strong>meaningful order.</strong></p>\n<p><strong>No size interval is defined</strong></p>\n</td>\n<td>\n<p>Arranged in a <strong>meaningful order </strong>with a<strong> well defined size interval</strong>.</p>\n<p>Example: Temperature in Celsius. If temperature in A is 40 deg Celsius and that in B is 20 deg Celsius, then A is 20 deg Celsius hotter than B (taking difference)</p>\n<p><strong>Does not have an absolute zero.</strong></p>\n<p>For example, Celsius scale has no such thing as &ldquo;no temperature&rdquo;. So the value cannot be zero.</p>\n</td>\n<td>\n<p>Arranged in a <strong>meaningful order </strong>with a<strong> well defined size interval</strong>.</p>\n<p>Eg: A pulse rate has well defined intervals and is meaningful in comparison. A 100/min pulse is exactly twice of 50 beats/min.</p>\n<p>&nbsp;</p>\n<p><strong>Has an absolute zero.</strong></p>\n<p>Eg: There can be a value of zero for pulse.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Type</p>\n</td>\n<td>\n<p><strong>Qualitative</strong></p>\n</td>\n<td>\n<p><strong>Qualitative</strong></p>\n</td>\n<td>\n<p><strong>Quantitative</strong></p>\n</td>\n<td>\n<p><strong>Quantitative</strong></p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB9253",
      "difficulty": "easy"
    },
    {
      "text": "An 18 month old child is brought with no history of vaccination. From the following, which vaccines would be appropriate to give this child according to the National Immunization Schedule (NIS), India?",
      "choices": [
        {
          "id": 1,
          "text": "DPT -1, OPV-1 only"
        },
        {
          "id": 2,
          "text": "BCG, DPT-1, OPV-1"
        },
        {
          "id": 3,
          "text": "BCG, DPT-1, OPV-1, Measles – 1, Vit. A -1"
        },
        {
          "id": 4,
          "text": "DPT-1, OPV-1, Measles – 1, Vit. A – 1"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<ul>\n<li>An <strong>18 month old</strong>, completely un-immunized child should receive first doses of DPT, OPV, measles vaccine and vitamin A, according to the National Immunization Schedule (NIS), India.</li>\n<li>BCG can be given only up to one year of age.</li>\n</ul><hr><h3>Related Pearl: National Immunization Schedule (India)</h3><table>\n<tbody>\n<tr>\n<td><strong>Vaccine</strong></td>\n<td><strong>When to give</strong></td>\n<td><strong>Dose</strong></td>\n<td><strong>Route</strong></td>\n<td><strong>Site</strong></td>\n</tr>\n<tr>\n<td colspan=\"5\"><strong>For Pregnant Women</strong></td>\n</tr>\n<tr>\n<td>Td-1</td>\n<td>\n<p>Early in pregnancy</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>Upper arm</td>\n</tr>\n<tr>\n<td>Td-2</td>\n<td>\n<p>4 weeks after Td-1*</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>Upper arm</td>\n</tr>\n<tr>\n<td>Td- Booster</td>\n<td>\n<p>If received 2 Td doses in a pregnancy <br />within the last 3 yrs*</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>Upper arm</td>\n</tr>\n<tr>\n<td colspan=\"5\"><strong>For Infants</strong></td>\n</tr>\n<tr>\n<td>BCG</td>\n<td>\n<p>At birth or as early as possible until one year of age</p>\n</td>\n<td>0.1 mL (0.05 mL until<br />1 month<br />age)</td>\n<td>Intra-dermal</td>\n<td>Left upper arm</td>\n</tr>\n<tr>\n<td>Hepatitis B - Birth Dose</td>\n<td>\n<p>At birth or as early as possible within 24 hrs</p>\n</td>\n<td>0.5 mL</td>\n<td> Intra-muscular</td>\n<td>Antero-lateral side of mid-thigh</td>\n</tr>\n<tr>\n<td>OPV - 0</td>\n<td>\n<p>At birth or as early as possible within the first 15 days</p>\n</td>\n<td>2 drops</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td>OPV-1, 2 &amp; 3</td>\n<td>\n<p>At 6 weeks, 10 weeks, &amp; 14 weeks (can be given until 5 years of age)</p>\n</td>\n<td>2 drops</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td>Pentavalent 1, 2 &amp; 3</td>\n<td>\n<p>At 6 weeks, 10 weeks, &amp; 14 weeks (can be given until one year of age)</p>\n</td>\n<td>0.5 mL</td>\n<td>lntra·muscular</td>\n<td>Antero-lateral side of mid-thigh</td>\n</tr>\n<tr>\n<td>Rotavirus</td>\n<td>\n<p>At 6 weeks, 10 weeks, &amp; 14 weeks (can be given until one year of age)</p>\n</td>\n<td>5 drops</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td>IPV</td>\n<td>\n<p>Two fractional doses at 6, 14 weeks </p>\n</td>\n<td>0.1 mL</td>\n<td>Intra-dermal two fractional dose</td>\n<td>Intra-dermal: right Upper arm (at 6, 14 weeks)<br /><br /></td>\n</tr>\n<tr>\n<td>\n<p>PCV</p>\n<p>(wherever applicable)</p>\n</td>\n<td>\n<p>At 6 weeks and 14 weeks; Booster at 9 completed months</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra·muscular</td>\n<td>Antero-lateral side of mid-thigh, right</td>\n</tr>\n<tr>\n<td>Measles/MR 1<sup>st</sup> Dose</td>\n<td>\n<p>9 completed months to 12 months<br />(Can be given till 5 years of age)</p>\n</td>\n<td>0.5ml</td>\n<td>Sub-cutaneous</td>\n<td>Right upper arm</td>\n</tr>\n<tr>\n<td>JE- 1**</td>\n<td>\n<p>9 completed months to 12 months</p>\n</td>\n<td>0.5 mL</td>\n<td>\n<p>Intramuscular(killed)/Subcutaneous (live attenuated)</p>\n</td>\n<td>\n<p>Anterolateral aspect of mid-thigh/Left upper arm </p>\n</td>\n</tr>\n<tr>\n<td>Vitamin A<br />(1st dose)</td>\n<td>\n<p>At 9 completed months with measles Rubella</p>\n</td>\n<td>1 mL (1 lakh IU)</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td colspan=\"5\"><strong>For Children </strong></td>\n</tr>\n<tr>\n<td>DPT booster-1</td>\n<td>\n<p>16–24 months</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>Antero-lateral side of mid-thigh  </td>\n</tr>\n<tr>\n<td>Measles / MR 2<sup>nd </sup>dose</td>\n<td>\n<p>16–24 months</p>\n</td>\n<td>0.5 mL</td>\n<td>Sub-cutaneous</td>\n<td>Right upper arm  </td>\n</tr>\n<tr>\n<td>OPV booster</td>\n<td>\n<p>16–24 months</p>\n</td>\n<td>2 drops</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td>JE-2</td>\n<td>\n<p>16–24 months</p>\n</td>\n<td>0.5 mL</td>\n<td>\n<p>Intramuscular (killed)/Subcutaneous (live attenuated)</p>\n</td>\n<td>Anterolateral aspect of mid-thigh/Left upper arm </td>\n</tr>\n<tr>\n<td>Vitamin A***<br />(2nd to 9<sup>th</sup> dose)</td>\n<td>\n<p>16–18 months, followed by one dose every 6 months up to the age of 5 years</p>\n</td>\n<td>2 mL (2 lakh IU)</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td>DPT booster 2</td>\n<td>\n<p>5–6 years</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>Upper arm</td>\n</tr>\n<tr>\n<td>Td</td>\n<td>10 years &amp; 16 years</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>\n<p>Upper arm</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>*Give Td-2 or booster doses before 36 weeks of pregnancy. However, give these even if more than 36 weeks have passed. Give Td to a woman in labor, if she has not previously received Td.</p>\n<p>**JE vaccine is introduced in select endemic districts after the campaigns. Intramuscular (killed inactivated) vaccine is gradually replacing the live attenuated vaccine. This change is because the killed vaccines are more effective and require fewer doses.</p>\n<p>***The 2nd to 9th doses of vitamin A can be administered to children 1–5 years old during biannual rounds, in collaboration with ICDS.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB9264",
      "difficulty": "easy"
    },
    {
      "text": "P-value is the probability of which of the following?",
      "choices": [
        {
          "id": 1,
          "text": "Not rejecting a null hypothesis when it is true"
        },
        {
          "id": 2,
          "text": "Rejecting a null hypothesis when it is true"
        },
        {
          "id": 3,
          "text": "Not rejecting a null hypothesis when it is false"
        },
        {
          "id": 4,
          "text": "Rejecting a null hypothesis when it is false"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong> p-value</strong> is the probability of <strong>rejecting</strong> a <strong>null</strong> hypothesis <strong>when it is true</strong>.</p>\n<p>The p-value is the criterion or<strong> significance level (&alpha;)</strong>, below which an outcome can be said to be <strong>statistically significant</strong>. From this, we can also deduce that the p-value is the probability that <strong>a null hypothesis will be rejected even when it is true</strong>, thereby making a <strong>type I error</strong>.</p><hr><h3>Related Pearl: Concepts in Hypothesis Testing</h3><p><strong>Probability value (</strong><em>p</em><strong> value)</strong></p>\n<ul>\n<li>A&nbsp;<strong>probability value</strong>&nbsp;is the&nbsp;<strong>probability of an outcome given the hypothesis</strong>.</li>\n<li>It is not the probability of the hypothesis given the outcome, although the probability of the given hypothesis is not ignored.</li>\n<li>If the&nbsp;<strong>probability of an outcome is sufficiently low</strong>, we have&nbsp;<strong>evidence that the hypothesis is false</strong>.</li>\n<li>It is also called the&nbsp;<em>p</em><strong> value</strong>.</li>\n</ul>\n<p><strong>The Null Hypothesis and Alternative Hypothesis</strong></p>\n<ul>\n<li>The <strong>hypothesis that an apparent effect or outcome is only due to chance is a null hypothesis</strong>.</li>\n<li>In other words, a null hypothesis is one where there is <strong>no difference between the specified sample and population</strong> and any observed difference is due to chance or some other error.</li>\n<li>A null hypothesis is represented by <strong>H<sub>0</sub></strong>.</li>\n<li>If the <strong>null hypothesis</strong> is <strong>rejected</strong> as false, then there is an <strong>alternative</strong> or <strong>experimental hypothesis (H<sub>A</sub>)</strong>, which is logically accepted.</li>\n</ul>\n<p><strong>Criterion or Significance Level</strong> <strong>(&alpha;) </strong></p>\n<ul>\n<li>If the probability value of an outcome is sufficiently low, then the null hypothesis is rejected.</li>\n<li>This <strong>point below which we would define the probability value as being low enough</strong> to reject the null hypothesis is called the <strong>criterion</strong> or <strong>significance level </strong>or<strong> &alpha; (alpha) level</strong>.</li>\n<li>When the null hypothesis is rejected, the effect or outcome is said to be <strong>statistically significant</strong>.</li>\n<li>By <strong>convention</strong> (but not always), the <strong>level of &alpha; is 0.05</strong>, i.e., if the probability value of an outcome is <strong>less than or equal to 0.05 (</strong><em>p</em><strong> value &le; 0.05)</strong>, then the null hypothesis is <strong>rejected</strong>.</li>\n<li>If it is <strong>greater than 0.05</strong>, then the null hypothesis is <strong>accepted</strong>.</li>\n<li>Although by convention the level of <strong>&alpha; is 0.05</strong>, it can be lower but cannot be any higher.</li>\n</ul>\n<p><strong>Type I Error</strong></p>\n<ul>\n<li>The interpretation of <strong><em>p</em> value &le; 0.05 </strong>is that an investigator can be 95% sure that the result was not obtained by chance.</li>\n<li>It also means that there is a 5% probability that the result was obtained by chance.</li>\n<li>From this, we can deduce that the <strong>null hypothesis might indeed be true even though we rejected it</strong>.</li>\n<li>This is <strong>a type I error</strong>. In other words, <strong>when an alternative hypothesis is accepted even when it is false and the null hypothesis is true</strong>, it is a <strong>type I error</strong> or <strong>false positive error</strong>.</li>\n<li>It is also called an <strong>alpha (&alpha;) error</strong> as it is <strong>related to the criterion &alpha;</strong>.</li>\n<li>The <strong>lower the &alpha; level</strong>, the <strong>lower the rate of a type I error</strong> being made.</li>\n<li>Thus, it can be said that <strong>&alpha; is the maximum tolerable probability that a type I error is being made</strong> and that the <strong>p value is the probability that a significant difference is declared when there is none</strong>.</li>\n</ul>\n<p><strong>Type II Error</strong></p>\n<ul>\n<li>The error that is made by <strong>rejecting an alternative hypothesis when it is true</strong> or <strong>failing to reject a null hypothesis when it is false</strong> is called a <strong>type II error</strong>.</li>\n<li>It is also called a <strong>false negative error </strong>and more commonly, as a <strong>beta (&beta;) error</strong>.</li>\n<li>If the null hypothesis is false, then the <strong>probability of a type II error</strong> is <strong>&beta;</strong>.</li>\n<li>The <strong>power of a statistical test</strong> is indicated by <strong>1&ndash;&beta;.</strong></li>\n</ul>\n<p><strong>Power of a Test</strong></p>\n<ul>\n<li>The <strong>power of a test</strong> is the <strong>ability</strong> of a statistical test to <strong>avoid a type II error</strong>, which depends on its <strong>ability to detect a false null hypothesis</strong>.</li>\n<li>It is <strong>equal to 1&ndash;&beta;</strong>, which is the <strong>probability that a false null hypothesis will be rejected</strong>.</li>\n<li>By <strong>convention</strong>, a test is required to have a <strong>power of 0.8</strong> (or a <strong>&beta; of 0.2</strong>) to be <strong>acceptable</strong>. This is to say that a study that has less than 80% chance of detecting a false null hypothesis is unacceptable.</li>\n<li><strong>Type I errors are easily reduced by reducing the criterion &alpha;</strong>.</li>\n<li>A <strong>test's power will increase</strong> in the following conditions:\n<ul>\n<li>If <strong>&alpha; increases</strong>, but this will increase the chance of a type I error.</li>\n<li>If the <strong>difference between </strong>the <strong>sample mean </strong>and<strong> hypothesized mean increases</strong>. This is also called <strong>effect size</strong>.</li>\n<li>If <strong>sampling error decreases</strong>.</li>\n<li>If the <strong>sample size (n) increases</strong>.</li>\n</ul>\n</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB2652",
      "difficulty": "medium"
    },
    {
      "text": "While testing the deleterious health hazards on a group of people after giving a new drug and a placebo, the following results were obtained as tabulated. Based on these results, which of the following is true?<div class='question-desc-html'><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td>Total participants</td>\n<td>People affected</td>\n</tr>\n<tr>\n<td>New drug</td>\n<td>15225</td>\n<td>1603</td>\n</tr>\n<tr>\n<td>Placebo</td>\n<td>15225</td>\n<td>1804</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div></div>",
      "choices": [
        {
          "id": 1,
          "text": "Absolute risk reduction (ARR) is 1% and relative risk reduction (RRR) is 0.1"
        },
        {
          "id": 2,
          "text": "Absolute risk reduction (ARR) is 10% and relative risk reduction (RRR) is 0.9"
        },
        {
          "id": 3,
          "text": "Absolute risk reduction (ARR) is 1% and relative risk reduction (RRR) is 10"
        },
        {
          "id": 4,
          "text": "Absolute risk reduction (ARR) is 10% and relative risk reduction (RRR) is 9"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>In the given scenario, absolute risk reduction (<strong>ARR</strong>) is <strong>1%</strong> and relative risk reduction (<strong>RRR</strong>) is <strong>0.1</strong>.</p>\n<p>Let us reconstruct the design table in the following way:</p>\n<table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td>Health hazard (+)</td>\n<td>Health hazard (-)</td>\n<td>Total</td>\n</tr>\n<tr>\n<td>New drug</td>\n<td>1603 (a)</td>\n<td>13622 (b)</td>\n<td>15225 (a+b)</td>\n</tr>\n<tr>\n<td>Placebo</td>\n<td>1804 (c)</td>\n<td>13421 (d)</td>\n<td>15225 (c+d)</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><strong>Relative risk (RR)</strong> is given as <strong>a/(a+b) &divide; c/(c+d)</strong>.</p>\n<p>RR = 1603/15225 &divide; 1804/15225 = 0.106/0.118 = 0.89&nbsp;<strong>&asymp;</strong><strong>&nbsp;0.90</strong>.&nbsp;</p>\n<p><strong>Relative risk reduction (RRR) = 1 &ndash; Relative risk</strong>. In this scenario, RRR = 1 &ndash; 0.9 = <strong>0.1 or 10%.</strong></p>\n<p><strong>Incidence</strong> of a disease is the <strong>absolute risk</strong> of contracting it.</p>\n<p>Absolute risk rate of the group using new drug = a/(a+b) = 1603/15225 = 0.106 or 10.6%&nbsp;&asymp; 11%.</p>\n<p>Absolute risk rate of the group using placebo = c/(c+d) = 1804/15225 = 0.118 or 11.8%&nbsp;&asymp; 12%.</p>\n<p><strong>Absolute risk reduction</strong> (ARR) is the difference in the absolute risk rates between the placebo and the drug. In this scenario, <strong>ARR</strong> = 12% - 11% = <strong>1%</strong>.</p><hr><h3>Related Pearl: Relative and Attributable Risk</h3><p>Relative Risk:</p>\n<ul>\n<li>Ratio of incidence of disease or death among exposed to that among the non-exposed is called <strong>relative risk (RR).</strong></li>\n<li>It is also called <strong>risk ratio</strong>.</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/f8f2d7bcf01a465699a42d1a750c87b8x1280x704.JPEG\" alt=\"Pearl Image\"><ul>\n<li>It is the direct measure of the <strong>strength of association</strong> between suspected cause and effect in <strong>cohort studies</strong>.</li>\n<li>RR &lt; 1 indicates inverse association(protective effect)</li>\n<li>RR = 1 indicates no association.</li>\n<li>RR &gt; 1 indicates positive association.</li>\n<li>RR of 2 indicates a 100% increase in risk.</li>\n<li>Relative risk calculation (RR) = [ a/(a+b) ]/ [ c/(c+d) ] where, </li>\n</ul>\n<table>\n<tbody>\n<tr>\n<td> </td>\n<td colspan=\"3\">Cancer</td>\n</tr>\n<tr>\n<td rowspan=\"3\">Exposure</td>\n<td> </td>\n<td>yes</td>\n<td>no</td>\n</tr>\n<tr>\n<td>yes</td>\n<td>a</td>\n<td>b</td>\n</tr>\n<tr>\n<td>no</td>\n<td>c</td>\n<td>d</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p> </p>\n<p>Attributable Risk:</p>\n<ul>\n<li><strong>Attributable risk (AR)</strong> is the <strong>difference</strong> in incidence rates or proportions of disease or death between an exposed and non-exposed group.</li>\n<li>It is expressed in <strong>percentage</strong> and gives the extent to which the disease can be attributed to the exposure in a <strong>cohort study.</strong></li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/c96f4beb9eb942899198d757d3388918x1280x904.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC9546",
      "difficulty": "hard"
    },
    {
      "text": "A new drug combination of chemotherapy and immunotherapy for metastatic melanoma was prescribed by a radiotherapist. It prolongs the survival. Which of the following is true in this situation?",
      "choices": [
        {
          "id": 1,
          "text": "Incidence increases and prevalence reduces"
        },
        {
          "id": 2,
          "text": "Incidence reduces and prevalence remains the same"
        },
        {
          "id": 3,
          "text": "Incidence remains the same and prevalence increases"
        },
        {
          "id": 4,
          "text": "Incidence reduces  and prevalence increases"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>By the new drug combination, the survival of the patient has increased, hence incidence remains the same while prevalence increases.</p>\n<p><br /><strong>Incidence</strong>: Number of new cases in a defined population in a specified period of time.<br /><strong>Prevalence:</strong> Number of old and new cases at a given point of time over a period of time.</p>\n<p><br /><strong>Options A, B, D:</strong>&nbsp;The treatment only prolongs the disease, it has nothing to do with the occurrence of cases thereby nothing to do with incidence.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC9549",
      "difficulty": "easy"
    },
    {
      "text": "Observe the following curves, which of the following is a true statement about sensitivity and specificity when the curve changes from green to pink?",
      "choices": [
        {
          "id": 1,
          "text": "Both sensitivity and specificity increase"
        },
        {
          "id": 2,
          "text": "Both sensitivity and specificity decrease"
        },
        {
          "id": 3,
          "text": "Sensitivity increases while specificity decreases"
        },
        {
          "id": 4,
          "text": "Sensitivity decreases while specificity increases"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Both <strong>sensitivity</strong> and <strong>specificity are higher </strong>in the test represented in pink (Test B) compared to the test represented in green (Test A).</p>\n<p>Sensitivity is the proportion of all people with the disease who test positive. It is the probability of the test being positive when the disease is present.</p>\n<p>Sensitivity = TP / (TP + FN) or<strong> Sensitivity = 1 – false-negative rate.</strong></p>\n<p>Specificity is the proportion of all people without the disease who test negative. It is the probability of the test being negative when the disease is absent.</p>\n<p>Specificity= TN / (TN + FP) or<strong> specificity= 1 – false-positive rate.</strong></p>\n<p>Test B has an increased number of true positives and true negatives and decreased number of false positives and negatives, compared to Test A. </p>\n<p>Hence leading to<strong> increased sensitivity and specificity.</strong></p><hr><h3>Related Pearl: Cut-off points in diagnostic tests</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/77956c061f8a417f980dc92fa3b56592x1199x1136.JPEG\" alt=\"Pearl Image\"><ul>\n<li>Highly <strong>sensitive</strong> test, when <strong>negative</strong>, <strong>rules out</strong> a disease. <strong>(Screening test)</strong></li>\n<li>Highly <strong>specific</strong> test, when <strong>positive</strong>, <strong>rules in</strong> a disease. <strong>(Confirmatory test)</strong></li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/fd3edf675b3f4e30a140e2ff769dc087x1200x1109.JPEG\" alt=\"Pearl Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/94e48ae863c74fbea0b8bfed13733accx1280x1199.JPEG\" alt=\"Pearl Image\"><p><strong>Sensitivity</strong> (True-positive rate): High sensitivity indicates low false-negative rate.</p>\n<p><strong>Specificity</strong>&nbsp;(True-negative rate): High specificity indicates low false-positive rate.</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/0756e6e153a94f78ac1f2e7feb59a809.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC9574",
      "difficulty": "medium"
    },
    {
      "text": "A study was conducted to compare the incidence of postpartum depression in mothers as compared to the sex of the child. For assessment, Edinburg Depression scaled score (EDSS) was used. The study was divided into mothers with male babies as one group to be compared with mothers with female babies. Which of the following statistical test will be used to determine the association?",
      "choices": [
        {
          "id": 1,
          "text": "Students t test"
        },
        {
          "id": 2,
          "text": "Paired t test"
        },
        {
          "id": 3,
          "text": "ANOVA"
        },
        {
          "id": 4,
          "text": "Chi square test"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The Chi-square test is used to compare <strong>qualitative</strong> data and compares<strong> 2 groups</strong> with independent measures. The variables used here are yes/no signifying the presence/absence of postpartum depression. Hence it is the most appropriate test here.</p>\n<p>Option A: Student’s t-test is for quantitative data. Here the data is qualitative, hence it can't be used.</p>\n<p>Option B: Paired t-test compares paired data or pre-intervention and post-intervention data of the same group. This doesn't apply here as the groups are not paired.</p>\n<p>Option C: ANOVA is used to compare more than 2 groups.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC9575",
      "difficulty": "medium"
    },
    {
      "text": "A one-and-half-year-old child was brought to the hospital with a history of breathlessness, fever, cough, and cold. On examination, respiratory rate was 46/min, and there were no chest retractions. Which is the most appropriate management?",
      "choices": [
        {
          "id": 1,
          "text": "Give IV antibiotics and observe"
        },
        {
          "id": 2,
          "text": "Give IV antibiotics and refer to higher centre"
        },
        {
          "id": 3,
          "text": "Oral antibiotics, warn of danger signs, and send home"
        },
        {
          "id": 4,
          "text": "No need of treatment only home remedies"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>From the given clinical scenario, it can be easily inferred that the child has <strong>pneumonia</strong>. The treatment for pneumonia for a child between <strong>2 months and 5 years</strong> of age is&nbsp;<strong>oral amoxicillin</strong> and <strong>home care advice</strong>.</p>\n<p>The following image gives the&nbsp;<strong>IMNCI</strong>&nbsp;classification for cough/difficulty in breathing in children.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/b23ea6e413f945dcbd85f451ae09e57fx1280x711.PNG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC9576",
      "difficulty": "easy"
    },
    {
      "text": "The following are the disease frequencies in a population. Based on the number of cases which of the following is the correct match?<div class='question-desc-html'><p>Disease 1: Number of cases last week 42 this week 43<br />Disease 2: Number of cases last week 2 and present week 42<br />Disease 3: Number of cases last week 6 and present week 1</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "Pandemic, endemic, sporadic"
        },
        {
          "id": 2,
          "text": "Sporadic, endemic, epidemic"
        },
        {
          "id": 3,
          "text": "Endemic, epidemic, sporadic"
        },
        {
          "id": 4,
          "text": "Endemic, sporadic, epidemic"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Disease 1- the <strong>cases</strong> have been almost the <strong>same</strong> so it has to be <strong>endemic</strong>.<br />Disease 2- there is an <strong>alarming increase</strong> in the number of cases. It has to be an <strong>epidemic.</strong><br />Disease 3- the number of cases has <strong>decreased</strong> <strong>without </strong>any<strong> explanation</strong> so it has to be <strong>sporadic</strong>.</p>\n<p><strong>Epidemic</strong> refers to the occurrence of a disease in <strong>excess</strong> of expected <strong>frequency</strong>.</p>\n<p>A<strong> pandemic </strong>is an<strong> </strong>epidemic affecting a <strong>large population</strong> over a <strong>large geographical area </strong>crossing international boundaries.</p>\n<p>An<strong> endemic </strong>disease is a <strong>regularly</strong> occurring disease in a population in <strong>expected frequency</strong> without any importation from outside.</p>\n<p><strong>Sporadic </strong>diseases present as <strong>scattered</strong> <strong>cases</strong> of infection <strong>without relation</strong> temporally/spatially.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC9577",
      "difficulty": "easy"
    },
    {
      "text": "Below is a diagram depicting the natural history of the disease. Which point marks the onset of symptoms?",
      "choices": [
        {
          "id": 1,
          "text": "Point A"
        },
        {
          "id": 2,
          "text": "Point B"
        },
        {
          "id": 3,
          "text": "Point C"
        },
        {
          "id": 4,
          "text": "Point D"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Point C represents a point where signs and symptoms appear.</p>\n<p>Various points marked in the image represent the following:</p>\n<p>Point A: Entry of <strong>infectious agent</strong> into the host.</p>\n<p>Point B: <strong>Pathological</strong> and physiological changes occur in the stage of the<strong> s</strong><strong>ubclinical phase. </strong>These changes are&nbsp;induced by the causative agent but are not sufficient enough to cause clinical signs and symptoms.</p>\n<p>Point C: Marks <strong>onset</strong> of clinical <strong>signs</strong> and <strong>symptoms.</strong></p>\n<p>Point D: Usual <strong>time of diagnosis </strong>at which&nbsp;clinical&nbsp;signs&nbsp;and&nbsp;symptoms&nbsp;are well&nbsp;evident.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/286471cc5d894f4eb0c2b760ad0b91a0x1280x908.JPEG\" alt=\"Explanation Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/8894745c29f847bab294a061643dd79d.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC9578",
      "difficulty": "easy"
    },
    {
      "text": "A researcher finds out a sensitive test to be positive for a person. For diagnosis, which of the following will hold true?",
      "choices": [
        {
          "id": 1,
          "text": "It confirms that the person does not have the disease"
        },
        {
          "id": 2,
          "text": "It suggests that if the disease is rare, the person surely has the disease"
        },
        {
          "id": 3,
          "text": "It confirms that the person has the disease if the disease is common"
        },
        {
          "id": 4,
          "text": "It is an expected finding in case the disease is prevalent"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>A sensitive test, if it is <strong>positive</strong> it&nbsp;<strong>confirms</strong> that the person has the <strong>disease</strong> if the <strong>disease is common.</strong></p>\n<p>The <strong>sensitivity&nbsp;</strong>of a screening test is the ability of the test to identify correctly those who have the disease. In other words, Sensitivity is the ability of a test to <strong>detect true positives</strong> (TP) out of total disease (TP+FN).</p>\n<p>Sensitivity = TP/ TP+FN</p><hr><h3>Related Pearl: Validity of a Screening Test</h3><ul>\n<li><strong>Validity/ accuracy </strong>of a screening test depends upon the <strong>sensitivity, specificity,</strong> and<strong> predictive accuracy</strong> of the test.</li>\n<li>It represents the closeness to a true value/ actual value.</li>\n<li>These are the <strong>inherent properties</strong> of a screening test.</li>\n<li>P<strong>P</strong>V and N<strong>P</strong>V are <strong>dependent</strong> on the <strong>P</strong>revalence of disease.</li>\n<li>Sensitivity &amp; Specificity are independent of prevalence of disease.</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/62275b1d441443bc92db11bb3add523ex1280x959.JPEG\" alt=\"Pearl Image\"><table>\n<tbody>\n<tr>\n<td colspan=\"2\"><strong>Formulae</strong>&nbsp;</td>\n</tr>\n<tr>\n<td><span>Sensitivity</span></td>\n<td><span><span>&nbsp; &nbsp; &nbsp;<strong>TP</strong>&nbsp; &nbsp;&nbsp;</span></span><br /><span><strong>TP</strong> + FN</span></td>\n</tr>\n<tr>\n<td><span>Specificity</span></td>\n<td><span><span>&nbsp; &nbsp; &nbsp;<strong>TN&nbsp; &nbsp;&nbsp;</strong></span><sub><br /></sub>FP + <strong>TN</strong></span></td>\n</tr>\n<tr>\n<td><span>Predictive value of a positive test (<strong>P</strong>PV)</span></td>\n<td><span><span>&nbsp; &nbsp; &nbsp;T<strong>P&nbsp; &nbsp;&nbsp;</strong></span><sub><br /></sub>T<strong>P</strong> + F<strong>P</strong></span></td>\n</tr>\n<tr>\n<td><span>Predictive value of a negative test (<strong>N</strong>PV)</span></td>\n<td><span><span>&nbsp; &nbsp; &nbsp;T<strong>N&nbsp; &nbsp;&nbsp;</strong>&nbsp;</span><sub><br /></sub>T<strong>N</strong> + F<strong>N</strong></span></td>\n</tr>\n<tr>\n<td><span>Percentage of false positives</span></td>\n<td><span><span>&nbsp; &nbsp; &nbsp;FP&nbsp; &nbsp; &nbsp;</span><sub><br /></sub>FP + TN</span></td>\n</tr>\n<tr>\n<td><span>Percentage of false negatives</span></td>\n<td><span><span>&nbsp; &nbsp; &nbsp;FN&nbsp; &nbsp; &nbsp;</span><sub><br /></sub>TP + FN</span></td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<ul>\n<li><strong>PPV</strong> varies <strong>directly</strong> with prevalence</li>\n<li><strong>NPV</strong> varies <strong>inversely</strong> with prevalence</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC9579",
      "difficulty": "medium"
    }
  ]
}